Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5750
+0.0456
+(8.61%)
At close: April 1 at 4:00:00 PM EDT
0.5800
+0.00
+(0.87%)
After hours: April 1 at 7:59:19 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -3.69 | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.8 | -- | -4.33 | -3.4 |
| EPS Actual | -6.75 | -3.69 | -3.4 | -15.22 |
| Difference | -2.95 | -- | 0.93 | -11.82 |
| Surprise % | -77.68% | -- | 21.54% | -347.65% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VINC | -- | -- | -- | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Leerink Partners: Outperform to Outperform | 10/8/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 4/9/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 4/1/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/7/2023 |
| Maintains | Chardan Capital: Buy | 11/17/2022 |
| Maintains | SVB Leerink: Outperform | 8/12/2022 |
Related Tickers
PLRZ Polyrizon Ltd.
0.3646
-1.19%
AEON AEON Biopharma, Inc.
0.5936
+2.43%
REVB Revelation Biosciences, Inc.
2.6000
-1.14%
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%
ELEV Elevation Oncology, Inc.
0.2475
-4.48%
ONCO Onconetix, Inc.
0.0757
-2.95%
ELAB PMGC Holdings Inc.
4.3300
-6.48%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.8900
+5.00%
AZTR Azitra, Inc.
0.2900
-4.29%
ENTO Entero Therapeutics, Inc.
0.4101
-14.58%